
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 984 | 884 | 984 | 935 | 1308 | - |
Fund Return | -1.56% | -11.65% | -1.56% | -2.21% | 5.52% | - |
Place in category | 609 | 659 | 609 | 241 | 101 | - |
% in Category | 63 | 67 | 63 | 37 | 21 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund C dist USD h | 16.02B | 2.03 | 3.36 | 4.59 | ||
Global Income Fund C div USD hedged | 16.02B | 2.03 | 3.37 | 4.60 | ||
JPI Global Income Fund C mth USD he | 16.02B | -0.13 | 3.00 | 4.16 | ||
JPI Global Income Fund D acc USD he | 16.02B | -0.38 | 1.96 | 3.11 | ||
JPI Global Income Fund D mth USD he | 16.02B | -0.39 | 1.92 | 3.09 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World Healthscience Fund D2u | 1.13B | 4.23 | 2.78 | 7.39 | ||
World Healthscience Fund X2 USD | 41.02M | 4.47 | 3.79 | 8.47 | ||
World Healthscience Fund A2 | 6.13B | 4.03 | 2.01 | 6.59 | ||
World Healthscience Fund E2 | 2.02B | 3.90 | 1.50 | 6.06 | ||
LU1960219225 | 1.24B | 4.28 | 3.01 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.74 | 757.94 | +3.49% | |
UnitedHealth | US91324P1021 | 8.39 | 587.83 | -1.94% | |
AbbVie | US00287Y1091 | 6.03 | 179.50 | +2.54% | |
AstraZeneca | GB0009895292 | 4.66 | 10,320.0 | +3.12% | |
Novo Nordisk B | DK0062498333 | 4.22 | 435.9 | +3.71% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review